FDA Wrongly Denied Orphan Drug Exclusivity, Depomed Claims
Depomed Inc. on Tuesday sued the U.S. Food and Drug Administration and the U.S. Department of Health and Human Services, alleging they wrongly denied the company market exclusivity for Gralise despite...To view the full article, register now.
Already a subscriber? Click here to view full article